Oncolytic virotherapy for pediatric malignancies: future prospects

por Waters, Alicia M, Friedman, Gregory K, Ring, Eric K, Beierle, Elizabeth A
Publicado 2016

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

por Ring, Eric K., Li, Rong, Moore, Blake P., Nan, Li, Kelly, Virginia M., Han, Xiaosi, Beierle, Elizabeth A., Markert, James M., Leavenworth, Jianmei W., Gillespie, G. Yancey, Friedman, Gregory K.
Publicado 2017

Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression

por Friedman, Gregory K., Bernstock, Joshua D., Chen, Dongquan, Nan, Li, Moore, Blake P., Kelly, Virginia M., Youngblood, Samantha L., Langford, Catherine P., Han, Xiaosi, Ring, Eric K., Beierle, Elizabeth A., Gillespie, G. Yancey, Markert, James M.
Publicado 2018

HGG-28. INTERIM ANALYSIS OF THE GCC1949 PHASE 2 TRIAL USING INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS

por Johnson, Theodore S, Pacholczyk, Rafal, Aguilera, Dolly, Berrong, Zuzana, Castellino, Robert C, Chi, Susan, Creager, Julianne, Eaton, Bree R, Fangusaro, Jason R, Huang, Chenbin, Hummel, Trent, Ingerski, Lisa, Kennedy, Eugene P, Ring, Eric, Sadek, Ramses F, Satpathy, Sarthak, Schniederjan, Matthew, Thomas, Beena E, Yeo, Kee Kiat, Bhasin, Manoj, MacDonald, Tobey J, Munn, David H
Publicado 2023